WebSep 4, 2024 · BOSTON – September 4, 2024 – TRIA, a partner-led architecture firm with a focus on designing unique spaces for science, technology, and corporate clients, announced today that it is designing a new headquarters in downtown Boston for Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a gastrointestinal (GI)-focused healthcare … WebMar 20, 2024 · Ironwood's headquarters is located at 100 Summer St. #2300, Boston, MA 02110. The main phone number is 617.621.7722. back to top. ... At Ironwood Pharmaceuticals, Inc., we strive to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are …
Ironwood Pharmaceuticals, Inc. - Company Overview
WebIronwood Pharmaceuticals’ commitment to redefining the standard of care for patients suffering from GI diseases and disorders is unwavering. We understand that debilitating GI diseases exist, and countless patients need meaningful and effective medicines. WebJun 13, 2024 · Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD), a GI-focused healthcare company, today announced that the company plans to relocate its headquarters to a new office in downtown Boston from its current location in Cambridge, Massachusetts.Ironwood’s new headquarters will occupy approximately 39,000 square … 饅 使い方
Sustainability - Ironwood Pharmaceuticals
WebWebsite: www.ironwoodpharma.com Headquarters: Cambridge, MA Size: 201 to 500 Employees Type: Company - Public (IRWD) Industry: Biotech & Pharmaceuticals Revenue: $100 to $500 million (USD) Competitors: Unknown Ironwood Pharmaceuticals Reviews 3.7 ★★★★★ 69 % Recommend to a Friend 79 % Approve of CEO Mark Mallon 16 Ratings 5.0 … WebJun 13, 2024 · Ironwood’s new headquarters will occupy approximately 39,000 square feet at 100 Summer Street. Ironwood anticipates the move to be completed in the fourth quarter of 2024, and expects to save more than $25 million in cash payments to its landlord over the following five years. WebIronwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients. One in five Americans suffer from GI diseases, resulting in millions of hospital … Mr. Emany has served as our chief financial officer since December 2024. Prior to … The Boston Globe named Ironwood Pharmaceuticals a Top Place to Work for … Our in-market product, LINZESS® (linaclotide), discovered in-house, is the … Ironwood Pharmaceuticals wants to make our careers website accessible to all … In November 2024 into a collaboration and license option agreement with COUR … Ironwood Pharmaceuticals. 100 Summer Street Suite 2300 Boston MA 02110. … Ironwood Pharmaceuticals is a patient-focused, biopharmaceutical company on … By providing your email address below, you are providing consent to Ironwood … One in five Americans suffer from GI diseases, resulting in millions of hospital … tarikh ajij odia singer